Companies: 10,795·Total market cap: $144.5T
GRI Bio, Inc.

GRI Bio, Inc.

GRINASDAQHealthcare● Active
$2.22
+$0.05(+2.30%)
Market Cap$199427
P/E Ratio—
52W High$80.36
52W Low$1.97
Shares OutstandingFinancialsRevenue

GRI Bio, Inc. (GRI) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

GRI · shares outstanding · updated Jun 10, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
98,162▲ +1399.57% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 6,546 in FY 2024
Diluted Shares Outstanding
98,162
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+1399.57%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-10

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+339.0%
2022 → 2025
5-Year CAGRincreasing
+156.1%
2020 → 2025
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 98,162
98,162
+1399.57%
FY 2024
Diluted Shares: 6,546
6,546
+314.83%
FY 2023
Diluted Shares: 1,578
1,578
+36.03%
FY 2022
Diluted Shares: 1,160
1,160
-90.00%
FY 2021
Diluted Shares: 11,602
11,602
+1202.13%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs GRI
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
GRI Bio, Inc.GRI
GRI Bio, Inc.YOU
98,162—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

GRI Bio, Inc. (GRI) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, GRI Bio, Inc. reports 98,162 basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

GRI Bio, Inc.'s basic shares outstanding (98,162) represents currently issued shares. Diluted shares outstanding (98,162) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

GRI Bio, Inc.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

GRI Bio, Inc. (GRI) shares outstanding history from 2018 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

GRI Bio, Inc. shares outstanding for the fiscal year ending December 31, 2025 were 98,162, a 1399.57% increase year-over-year. GRI Bio, Inc. FY 2025 shares outstanding were 98,162, a +1399.57% increase from FY 2024.

GRI Bio, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

GRI shares outstanding · 4 questions

As of December 31, 2025, GRI Bio, Inc. (GRI) has approximately 98,162 basic shares outstanding and 98,162 diluted shares outstanding. This represents a +1399.57% year-over-year increase from FY 2024 (6,546). The increase may reflect equity compensation issuances or secondary offerings.

GRI shares outstandinghow many shares does GRI haveGRI basic shares 2025GRI diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · GRI Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10